Why a typically blas é event is a big deal for this Peninsula biotech

After ups and downs for the onetime potential rheumatoid arthritis drug, the FDA's acceptance of a new-drug application is a big deal, pointing toward an April approval decision for the drug for a bleeding disorder.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news